PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 14, 2017Medical Care47 citationsOpen Access

Using Self-reports or Claims to Assess Disease Prevalence

View Full Paper
PCPatricia St. ClairÉGÉtienne GaudetteHZHenu Zhao

Key Points

Key points are not available for this paper at this time.

Abstract

BACKGROUND: Two common ways of measuring disease prevalence include: (1) using self-reported disease diagnosis from survey responses; and (2) using disease-specific diagnosis codes found in administrative data. Because they do not suffer from self-report biases, claims are often assumed to be more objective. However, it is not clear that claims always produce better prevalence estimates. OBJECTIVE: Conduct an assessment of discrepancies between self-report and claims-based measures for 2 diseases in the US elderly to investigate definition, selection, and measurement error issues which may help explain divergence between claims and self-report estimates of prevalence. DATA: Self-reported data from 3 sources are included: the Health and Retirement Study, the Medicare Current Beneficiary Survey, and the National Health and Nutrition Examination Survey. Claims-based disease measurements are provided from Medicare claims linked to Health and Retirement Study and Medicare Current Beneficiary Survey participants, comprehensive claims data from a 20% random sample of Medicare enrollees, and private health insurance claims from Humana Inc. METHODS: Prevalence of diagnosed disease in the US elderly are computed and compared across sources. Two medical conditions are considered: diabetes and heart attack. RESULTS: Comparisons of diagnosed diabetes and heart attack prevalence show similar trends by source, but claims differ from self-reports with regard to levels. Selection into insurance plans, disease definitions, and the reference period used by algorithms are identified as sources contributing to differences. CONCLUSIONS: Claims and self-reports both have strengths and weaknesses, which researchers need to consider when interpreting estimates of prevalence from these 2 sources.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Clair et al. (2017) studied this question.

synapsesocial.com/papers/69f53ecde0fbb6efbd2037e0https://doi.org/10.1097/mlr.0000000000000753
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Validity of gout diagnoses in administrative data2007 · 93 citations
  2. 2Data Sources for Measuring Comorbidity2006 · 165 citations
  3. 3Agreement between Self-Reported Information and Medical Claims Data on Diagnosed Diabetes in Oregonʼs Medicaid Population2003 · 28 citations
  4. 4The accuracy of medicare claims data in identifying Alzheimer's disease2002 · 263 citations
  5. 5Failure of ICD‐9‐CM Codes to Identify Patients with Comorbid Chronic Kidney Disease in Diabetes2005 · 167 citations